What is the incidence of mesothelioma in the United Kingdom (UK)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Mesothelioma in the UK

The UK has one of the highest incidence rates of mesothelioma in the world, with approximately 2500 deaths per year currently, making it a significant public health concern despite being a relatively rare cancer. 1

Epidemiological Data

Mesothelioma in the UK is characterized by the following epidemiological features:

  • Overall incidence: According to the British Thoracic Society (BTS), there were approximately 2500 deaths per year in the UK as of 2018, with this rate expected to continue through the rest of the decade before beginning to fall 1

  • Case distribution: The 2016 Mesothelioma Audit reported that in 2014, there were 2179 cases (97%) of pleural mesothelioma and 70 cases (3%) of peritoneal mesothelioma in the UK 1

  • Gender distribution: Mesothelioma affects men at a significantly higher rate than women, with males accounting for 83% of cases 1

  • Age distribution: It is predominantly a disease of older adults with a median age at diagnosis of 73 years 1

  • Regional variation: Highest incidence occurs along the Thames and its estuary, reflecting historical areas of asbestos use in shipbuilding and industry 2

Asbestos Exposure and Risk Factors

  • Approximately 85% of mesothelioma cases in males are attributable to occupational asbestos exposure 1

  • The UK banned the use of asbestos products in 1999, but due to the long latency period (typically 30-40 years between exposure and disease development), cases continue to occur 1

  • Even areas without heavy industrial use of asbestos have reported high incidence rates, with one study from Exeter showing an incidence rate of 12.1 per 100,000 per year in men over 40 years 3

Trends and Projections

  • The incidence of mesothelioma has been increasing steadily since systematic recording began in the late 1960s 1

  • According to ESMO guidelines, the UK has one of the highest incidence rates in Europe at 1.25/100,000 population 1

  • The UK is considered one of the countries with the greatest previous asbestos use, alongside the Netherlands and Australia 1

  • Current projections suggest the number of cases will begin to fall after this decade, reflecting the impact of asbestos bans implemented decades ago 1

Survival and Outcomes

  • Overall median survival is 9.5 months, with 1-year and 3-year survival rates of 41% and 12%, respectively 1

  • Treatment patterns and outcomes show significant variation across different regions of the UK 1

  • 67% of patients receive active anticancer treatment (chemotherapy, radiotherapy, or surgery) 1

Clinical Implications

  • The high incidence of mesothelioma in the UK necessitates continued vigilance in recognizing symptoms in at-risk populations, particularly older men with history of potential asbestos exposure

  • Healthcare providers should maintain a high index of suspicion even in areas without traditional heavy industrial exposure to asbestos

  • The significant burden of disease underscores the importance of specialized mesothelioma multidisciplinary teams and treatment centers to optimize care

The UK's high incidence of mesothelioma reflects its historical industrial use of asbestos, with cases continuing to emerge decades after exposure due to the long latency period of the disease. While incidence is expected to decline in coming years, mesothelioma remains a significant health concern requiring specialized expertise in diagnosis and management.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.